Optimi Health Secures CAD$18.4M in Nasdaq Offering, Resolving Going Concern Doubts Amidst Significant Dilution

summarizeSummary

Optimi Health Corp. has finalized a Nasdaq public offering, raising CAD$18.4 million, which addresses its going concern warning but results in substantial dilution for existing shareholders.

check_boxKey Events · Financing and Capital Events · OPTH

• Successful Nasdaq Public Offering

  The company completed an underwritten public offering, issuing 2.4 million common shares for gross proceeds of USD$15 million, resulting in net proceeds of approximately CAD$18.4 million after expenses.

• Resolution of Going Concern

  The significant capital raise addresses the previously disclosed 'significant doubt on the Company's ability to continue as a going concern,' providing sufficient cash resources for at least the next twelve months.

• Significant Share Dilution

  The offering of 2.4 million new shares represents approximately 74.4% dilution to the 3,225,899 common shares outstanding as of March 31, 2026.

• Q1 2026 Financial Results

  For the six-month period ended March 31, 2026, the company reported a net loss of CAD$3,145,846 and a working capital deficiency of CAD$9,269,451.

auto_awesomeAnalysis · OPTH · Life Sciences

This filing confirms the successful completion of a substantial public offering on the Nasdaq Capital Market, raising CAD$18.4 million in net proceeds. This capital infusion is critical as it explicitly resolves the previously stated significant doubt about the company's ability to continue as a going concern. However, the offering involved issuing 2.4 million common shares, representing approximately 74.4% dilution to existing shareholders, a significant cost for the company's survival. The filing also provides the Q1 2026 financial results, showing a net loss and working capital deficiency, which the new capital is intended to address.